Ligand validation:9IIL

EDO: 1,2-ETHANEDIOL

EDO is a Ligand Of Interest in 9IIL designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9IIL_EDO_D_404	76%	91%	0.101	0.936	0.16	0.42	-	-	0	0	100%	1
9IIL_EDO_D_407	75%	98%	0.098	0.931	0.07	0.18	-	-	0	0	100%	1
9IIL_EDO_B_404	68%	91%	0.098	0.909	0.21	0.37	-	-	0	0	100%	1
9IIL_EDO_D_406	63%	78%	0.133	0.929	0.35	0.53	-	-	0	0	100%	1
9IIL_EDO_A_405	52%	91%	0.158	0.914	0.21	0.35	-	-	0	0	100%	1
9IIL_EDO_D_405	48%	70%	0.118	0.859	0.38	0.77	-	-	2	0	100%	1
9IIL_EDO_A_406	44%	95%	0.162	0.891	0.13	0.26	-	-	0	0	100%	1
9IIL_EDO_A_404	41%	86%	0.172	0.886	0.23	0.48	-	-	1	0	100%	1
9IIL_EDO_C_407	35%	93%	0.217	0.905	0.13	0.35	-	-	2	0	100%	1
9IIL_EDO_C_405	34%	93%	0.162	0.843	0.15	0.33	-	-	0	0	100%	1
9IIL_EDO_B_411	33%	99%	0.158	0.835	0.09	0.12	-	-	0	0	100%	1
9IIL_EDO_B_407	27%	93%	0.208	0.855	0.12	0.34	-	-	0	0	100%	1
8ZN4_EDO_C_404	73%	89%	0.088	0.913	0.2	0.42	-	-	0	0	100%	1
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.7
3DPJ_EDO_B_195	100%	82%	0.022	0.994	0.47	0.34	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.